Hi, I'm Oliver, the Editor for our Online Content. Feel free to email me at editorial.dept@lawyer-monthly.com if you have any questions or interesting content to send over!
As of 2020, Merck & Co.’s Keytruda (also known as Pembrolizumab) has been approved for use in metastatic mesothelioma patients to diminish tumour volume, but only if they have certain specific genetic markers. It is most effective when it’s used in combination with other therapies, but even then its effect is moderate at best.
Choosing the right attorney is fundamental to any personal injury claim. Before you hire someone to represent you, be sure to learn all you can about them.
In what is believed to be the first case of its kind, the Australian government faces a class action lawsuit for alleged failure to disclose the risks of climate change to bond-buyers.
A series of notable cases have brought private prosecutions into the public eye. What are the uses of this type of proceeding, and what are its ethical pitfalls?
Lawyer Monthly is a news website and monthly legal publication with content that is entirely defined by the significant legal news from around the world.
We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you consent to the use of cookies. Privacy PolicyOkI do not consent